VALENCE, France--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans), a leading French player on the surgical technology market for ...

As of 3:32 PM GMT+2. Market Open. VALENCE, France, July 25, 2024--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical ...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin ...

For the first 9 months (July 2004 - March 2025) of the 2024-25 financial year, Amplitude Surgical sales came to €83.8 million, up +5.3% and +6.4% at constant exchange rates. Over the 9 months, sales ...

In the first quarter (July-September 2024) of the 2024-25 financial year, Amplitude Surgical sales came to €21.8 million, up 6.1% and 7.5% at constant exchange rates. Sales in France rose by 4.5%, ...

PAI Partners is in exclusive talks to acquire a majority stake in Amplitude Surgical for 2.15 euros per share. The sellers include Apax Partners. The proposed deal could close in the second half of ...

Annual sales of €95.5 million, +8.2% in actual terms and +10.0% at constants exchange rates EBITDA of €20.6 million, representing 21.6% of sales Cash position and cash equivalents of €30.7 million at ...

Consolidated sales of €100.2 million, +14.0% at constant exchange rates Increase in EBITDA to €26.1 million (+18.7%), EBITDA margin of 26.1% Recurring operating profit of €10.3 million Cash position ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Amplitude Surgical announced it has acquired a 50% stake ...

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible). Following the announcement of the envisaged tender offer on March 11, 2025 of Zydus Lifesciences Limited on the Amplitude ...

During the 2024-25 financial year, Amplitude Surgical's revenue amounted to €110.8 million, up 4.5% at current exchange rates and 5.7% at constant exchange rates. Revenue for the 2024-25 financial ...

Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME), the French leader in surgical technologies for lower limb orthopedics. On 10 October 2025, the French Autorité des Marchés ...